McKesson Europe AG CAKFY OTC

McKesson Europe AG (CAKFY) reported total assets of $5.1B and total liabilities of $2.58B for fiscal year 2021, resulting in total equity of $2.52B.

The company held $5.3M in cash and short-term investments. Total debt stood at $183.9M, with net debt of $178.6M. The Debt-to-Equity (D/E) ratio was 0.07 (conservative).

Current ratio is 1.82, indicating strong short-term liquidity. Interest coverage is 3.8x (adequate).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.07, current ratio of 1.82, interest coverage 3.8x — balance sheet is strong
• MOAT (35/100) — Total assets $5.1B and equity $2.52B support the company's competitive scale

Overall SharesGrow Score: 32/100 with 1/7 criteria passed.

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%

RHHBF

Roche Holding AG

$418.50

+1.82%

RHHBY

Roche Holding AG

$51.02

+0.65%

AZN

AstraZeneca PLC

$204.38

+1.06%

NVSEF

Novartis AG

$156.48

+0.00%

MRK

Merck & Co., Inc.

$119.96

-0.16%